Briefing.com

Upgrades/Downgrades

Updated: 28-Oct-26 09:45 ET

Upgrades
Company Ticker Brokerage Firm Ratings Change Price Target
Softbank SFTBY Jefferies Underperform » Hold
Sun Life SLF Scotiabank Sector Perform » Sector Outperform
Texas Instruments TXN DZ Bank Sell » Hold $300
Pentair PNR BNP Paribas Exane Underperform » Neutral $65
Chemed CHE Jefferies Hold » Buy $620
Downgrades
Company Ticker Brokerage Firm Ratings Change Price Target
Equinor EQNR DZ Bank Buy » Hold
Seagate Tech STX Summit Insights Buy » Hold
Datavault AI DVLT Maxim Group Buy » Hold
Enphase Energy ENPH Roth Capital Buy » Neutral $30
Manulife Financial MFC Scotiabank Sector Outperform » Sector Perform
Xylem XYL JP Morgan Overweight » Neutral $90
Whirlpool WHR Stifel Hold » Sell $20
Simply Good Foods SMPL Jefferies Buy » Hold $11
Kosmos Energy KOS Jefferies Buy » Hold $2.90
F5 Networks FFIV Piper Sandler Overweight » Neutral $461
Enphase Energy ENPH Oppenheimer Outperform » Perform
Dyne Therapeutics DYN Oppenheimer Outperform » Perform $15
Coverage Initiated
Company Ticker Brokerage Firm Ratings Change Price Target
Procore Technologies PCOR Griffin Securities Buy $82
C4 Therapeutics CCCC Lake Street Buy $11
Anfield Energy AEC Roth Capital Buy $5
Cavco Industries CVCO Northland Capital Outperform $650
Alignment Healthcare ALHC Needham Hold
Clover Health CLOV Needham Buy $6
MSG Rangers Corp MSGR Guggenheim Buy $278
Silicon Motion SIMO China Renaissance Buy $300
Spero Therapeutics SPRO Cantor Fitzgerald Overweight $6
Lakewood-Amedex Biotherapeutics LABT H.C. Wainwright Buy $3
(a) Brokerage firm initiating coverage participated in underwriting the recent IPO.
(b) Brokerage firm resumes coverage.
(c) Brokerage firm participated in the secondary offering.
* This list of reiterations/target changes is not comprehensive.

Copyright © Briefing.com. All rights reserved.